EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine
- Product NDC
- 29485-8028
- 11-digit product format
- 294858028
- Labeler code
- 29485
- Product ID
- 29485-8028_e65e5d44-5171-53b4-e053-2a95a90a0b7d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Aspirin, and Caffeine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mechanical Servants LLC
- Application
- NDA020802
- Marketing category
- NDA
- Marketing start
- 2010-02-15
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 29485-8028 | D | Discontinued by firm | 2026-08-07 | ||
| excluded package | package | 29485-8028 | 29485-8028-6 | D | Discontinued by firm | 2026-08-07 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | ACETAMINOPHEN; ASPIRIN; CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020802-001 | EXCEDRIN (MIGRAINE RELIEF) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N020802-001 | EXCEDRIN (MIGRAINE) | 250MG;250MG;65MG | TABLET / ORAL | RLD, RS | 1998-01-14 | cb3db0bc1861… |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 29485-8028 | EXCEDRIN MIGRAINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE (ACETAMINOPHEN, ASPIRIN, AND CAFFEINE) TABLET, FILM COATED [LIL' DRUG STORE PRODUCTS, INC.] | 5 | Legacy NDC | 20230721_20406b7d-c989-40a5-b066-f3336c27a5fa.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-07-03 | Warnings | 020802 NDA020802 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Navajo Manufacturing Company Inc. | 4efbd21b-92fe-96a7-e063-6294a90ac4ad | 2026-04-08 | Warnings | 020802 NDA020802 |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Haleon US Holdings LLC | 7ed841fb-a61c-4868-b4e5-4f2311a5e79c | 2025-06-25 | Warnings | 020802 NDA020802 |
| Excedrin Migraine Relief | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Haleon US Holdings LLC | dd85f3a7-f4d2-4ea0-a7b6-18ebc0e993d8 | 2025-03-11 | Warnings | 020802 NDA020802 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Haleon US Holdings LLC | 910d7254-d0f4-4c5c-a26e-7f8acecbe02d | 2025-03-11 | Warnings | 020802 NDA020802 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN, CAFFEINE | JC World Bell Wholesale Co., Inc | 29b764c7-3d07-5191-e063-6294a90a9c30 | 2024-12-23 | Warnings | 020802 NDA020802 |
| Excedrin Migraine, TRAVEL BASIX | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Lil' Drug Store Products, Inc. | 40aeb2c5-a37b-446d-9918-8378a75ff327 | 2024-12-13 | Warnings | 020802 NDA020802 |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | A-S Medication Solutions | d012ed1d-b256-48ec-b988-f226c2c5ae9e | 2024-05-29 | Warnings | 020802 NDA020802 |
| EXCEDRIN MIGRAINE | ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE | Haleon US Holdings LLC | 920c8898-e222-4b91-afc5-04d25317ade7 | 2024-03-14 | Warnings | 020802 NDA020802 |
| Excedrin Migraine Geltabs | ACETAMINOPHEN, ASPRIN, CAFFEINE | Haleon US Holdings LLC | cc2f4a6f-2a27-4a60-b5ef-ae0bb0988ff8 | 2024-01-28 | Warnings | 020802 NDA020802 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Allegiant Health | 6197eff5-0351-42ef-bb3f-cbc26e6d0d14 | 2018-12-28 | Warnings | 020802 NDA020802 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 29485-8028-6 | 29485802806 | 3 POUCH in 1 CARTON (29485-8028-6) > 2 TABLET, FILM COATED in 1 POUCH | 3 pouch | 2010-02-15 | 0000-00-00 | No | No | Current |